Connection

W. Garvey to Mice, Transgenic

This is a "connection" page, showing publications W. Garvey has written about Mice, Transgenic.
Connection Strength

0.222
  1. AP2-NR4A3 transgenic mice display reduced serum epinephrine because of increased catecholamine catabolism in adipose tissue. Am J Physiol Endocrinol Metab. 2016 Jul 01; 311(1):E69-81.
    View in: PubMed
    Score: 0.106
  2. Exercise in transgenic mice overexpressing GLUT4 glucose transporters: effects on substrate metabolism and glycogen regulation. Metabolism. 1997 Nov; 46(11):1349-57.
    View in: PubMed
    Score: 0.029
  3. AdR1-TG/TALLYHO mice have improved lipid accumulation and insulin sensitivity. Biochem Biophys Res Commun. 2013 Apr 19; 433(4):567-72.
    View in: PubMed
    Score: 0.021
  4. Enhanced adiponectin actions by overexpression of adiponectin receptor 1 in macrophages. Atherosclerosis. 2013 May; 228(1):124-35.
    View in: PubMed
    Score: 0.021
  5. Effects of macrophage-specific adiponectin expression on lipid metabolism in vivo. Am J Physiol Endocrinol Metab. 2011 Jul; 301(1):E180-6.
    View in: PubMed
    Score: 0.019
  6. Macrophage adiponectin expression improves insulin sensitivity and protects against inflammation and atherosclerosis. Diabetes. 2010 Apr; 59(4):791-9.
    View in: PubMed
    Score: 0.017
  7. Mechanism of hexosamine-induced insulin resistance in transgenic mice overexpressing glutamine:fructose-6-phosphate amidotransferase: decreased glucose transporter GLUT4 translocation and reversal by treatment with thiazolidinedione. Endocrinology. 1999 Mar; 140(3):1151-7.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.